Avantor, Inc. (NYSE:AVTR) Director Gregory L. Summe Buys 30,000 Shares

Avantor, Inc. (NYSE:AVTR - Get Free Report) Director Gregory L. Summe purchased 30,000 shares of Avantor stock in a transaction dated Friday, May 23rd. The shares were purchased at an average price of $12.50 per share, with a total value of $375,000.00. Following the completion of the transaction, the director now directly owns 100,000 shares in the company, valued at approximately $1,250,000. This represents a 42.86% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link.

Avantor Trading Down 1.0%

NYSE AVTR traded down $0.13 during trading on Friday, hitting $12.91. 11,443,298 shares of the company's stock traded hands, compared to its average volume of 7,966,405. Avantor, Inc. has a 12-month low of $11.82 and a 12-month high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The stock has a fifty day moving average of $14.15 and a two-hundred day moving average of $18.02. The firm has a market cap of $8.80 billion, a P/E ratio of 12.41, a PEG ratio of 1.55 and a beta of 1.09.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business's revenue was down 5.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.22 earnings per share. As a group, sell-side analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Stifel Nicolaus lowered Avantor from a "buy" rating to a "hold" rating and decreased their target price for the stock from $26.00 to $14.00 in a research note on Monday, April 28th. Royal Bank of Canada lowered their target price on shares of Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. TD Cowen cut shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target for the company. in a research note on Monday, April 28th. Robert W. Baird decreased their price target on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Barclays dropped their price objective on shares of Avantor from $18.00 to $15.00 and set an "overweight" rating for the company in a report on Monday, April 28th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Avantor has an average rating of "Hold" and a consensus price target of $18.88.

Hedge Funds Weigh In On Avantor

A number of hedge funds have recently modified their holdings of AVTR. Rise Advisors LLC bought a new stake in shares of Avantor in the first quarter worth about $25,000. Smartleaf Asset Management LLC lifted its holdings in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after buying an additional 830 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of Avantor by 288.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company's stock worth $28,000 after buying an additional 1,263 shares during the last quarter. Wealthquest Corp purchased a new position in shares of Avantor during the first quarter valued at approximately $34,000. Finally, Global Retirement Partners LLC increased its stake in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock valued at $52,000 after buying an additional 1,067 shares during the period. Hedge funds and other institutional investors own 95.08% of the company's stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.